2/5
06:09 am
cnmd
CONMED (NYSE:CNMD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
CONMED (NYSE:CNMD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
1/29
09:21 am
cnmd
CONMED (NYSE:CNMD) had its price target raised by analysts at Wells Fargo & Company from $41.00 to $42.00. They now have an "equal weight" rating on the stock.
Medium
Report
CONMED (NYSE:CNMD) had its price target raised by analysts at Wells Fargo & Company from $41.00 to $42.00. They now have an "equal weight" rating on the stock.
1/29
08:03 am
cnmd
CONMED (NYSE:CNMD) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Medium
Report
CONMED (NYSE:CNMD) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
1/29
12:13 am
cnmd
Conmed Corp (CNMD) Q4 2025 Earnings Call Highlights: Strong Orthopedic Sales Drive Growth ... [Yahoo! Finance]
Medium
Report
Conmed Corp (CNMD) Q4 2025 Earnings Call Highlights: Strong Orthopedic Sales Drive Growth ... [Yahoo! Finance]
1/28
08:53 pm
cnmd
CONMED Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
CONMED Q4 Earnings Call Highlights [Yahoo! Finance]
1/28
07:26 pm
cnmd
Conmed outlines 2026 revenue target of $1.345B–$1.375B while advancing portfolio focus and supply chain improvements [Seeking Alpha]
Medium
Report
Conmed outlines 2026 revenue target of $1.345B–$1.375B while advancing portfolio focus and supply chain improvements [Seeking Alpha]
1/28
04:05 pm
cnmd
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results
Medium
Report
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results
1/8
05:17 pm
cnmd
CONMED Corporation Announces Chief Financial Officer Transition [Yahoo! Finance]
Low
Report
CONMED Corporation Announces Chief Financial Officer Transition [Yahoo! Finance]
1/8
04:55 pm
cnmd
CONMED Corporation Announces Chief Financial Officer Transition
Low
Report
CONMED Corporation Announces Chief Financial Officer Transition
1/5
04:10 pm
cnmd
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/5
04:05 pm
cnmd
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
Medium
Report
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
1/3
05:42 am
cnmd
CONMED (NYSE:CNMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
CONMED (NYSE:CNMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
12/8
08:13 am
cnmd
CONMED (NYSE:CNMD) had its price target lowered by analysts at Bank of America Corporation from $65.00 to $52.00. They now have a "neutral" rating on the stock.
Low
Report
CONMED (NYSE:CNMD) had its price target lowered by analysts at Bank of America Corporation from $65.00 to $52.00. They now have a "neutral" rating on the stock.
12/5
08:00 am
cnmd
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
Medium
Report
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines